These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27475788)

  • 1. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.
    Ladhani SN; Beebeejaun K; Lucidarme J; Campbell H; Gray S; Kaczmarski E; Ramsay ME; Borrow R
    Clin Infect Dis; 2015 Feb; 60(4):578-85. PubMed ID: 25389259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.
    Campbell H; Andrews N; Parikh S; Ribeiro S; Gray S; Lucidarme J; Ramsay ME; Borrow R; Ladhani SN
    J Infect; 2020 Feb; 80(2):182-189. PubMed ID: 31715210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources.
    Ladhani SN; Waight PA; Ribeiro S; Ramsay ME
    BMC Infect Dis; 2015 Dec; 15():551. PubMed ID: 26626321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of PCR-testing for confirmation of invasive meningococcal disease in England.
    Heinsbroek E; Ladhani S; Gray S; Guiver M; Kaczmarski E; Borrow R; Ramsay M
    J Infect; 2013 Nov; 67(5):385-90. PubMed ID: 23796865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.
    Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R
    Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015.
    Parikh SR; Campbell H; Gray SJ; Beebeejaun K; Ribeiro S; Borrow R; Ramsay ME; Ladhani SN
    Vaccine; 2018 Jun; 36(26):3876-3881. PubMed ID: 29699791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system.
    Baldovin T; Lazzari R; Cocchio S; Furlan P; Bertoncello C; Saia M; Russo F; Baldo V
    BMJ Open; 2017 May; 7(4):e012478. PubMed ID: 28465304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine.
    Mandal S; Campbell H; Ribeiro S; Gray S; Carr T; White J; Ladhani SN; Ramsay ME
    Vaccine; 2017 Oct; 35(43):5814-5818. PubMed ID: 28928076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018.
    Koliou M; Kasapi D; Mazeri S; Maikanti P; Demetriou A; Skordi C; Agathocleous M; Tzanakaki G; Constantinou E
    Euro Surveill; 2020 Jul; 25(30):. PubMed ID: 32734853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.
    Simmons RD; Kirwan P; Beebeejaun K; Riordan A; Borrow R; Ramsay ME; Delpech V; Lattimore S; Ladhani S
    BMC Med; 2015 Dec; 13():297. PubMed ID: 26654248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underestimation of Invasive Meningococcal Disease in Italy.
    Azzari C; Nieddu F; Moriondo M; Indolfi G; Canessa C; Ricci S; Bianchi L; Serranti D; Poggi GM; Resti M
    Emerg Infect Dis; 2016 Mar; 22(3):469-75. PubMed ID: 26890305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    Parent du Chatelet I; Deghmane AE; Antona D; Hong E; Fonteneau L; Taha MK; Lévy-Bruhl D
    J Infect; 2017 Jun; 74(6):564-574. PubMed ID: 28279715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    De Wals P; Deceuninck G; Lefebvre B; Tsang R; Law D; De Serres G; Gilca V; Gilca R; Boulianne N
    Clin Infect Dis; 2017 May; 64(9):1263-1267. PubMed ID: 28207068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children.
    Wang B; Haji Ali Afzali H; Marshall H
    Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.